Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma PCSK9 levels in children and adolescents: evidence from an Italian outpatient paediatric clinic cohort at cardio-metabolic risk.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026
Same author

Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Patients cared for in the Corridor of a large hospital in the United Kingdom: Sick, elderly, and sad.

Acute medicine·2025
Same author

Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2023
Same author

Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2021

Related Experiment Video

Updated: Jun 14, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Melanoma with an unknown primary--a case series.

J K O'Neill1, R Khundar, L Knowles

  • 1Department of Plastic Surgery, Frenchay Hospital, Frenchay Park Road, Bristol, BS16 1LE, United Kingdom. jenniferoneill@hotmail.com

Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|March 26, 2010
PubMed
Summary

Metastatic melanoma of unknown primary site (MUP) affects 5-10% of patients. This study examines 24 MUP cases, discussing their characteristics and outcomes to understand this challenging diagnosis.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Experiment Videos

Last Updated: Jun 14, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Area of Science:

  • Oncology
  • Dermatology
  • Pathology

Background:

  • Metastatic melanoma of unknown primary site (MUP) represents a significant clinical challenge, accounting for 5-10% of all metastatic melanoma cases.
  • The etiology of MUP remains multifactorial, with proposed causes including occult primary tumors, complete regression of the primary lesion, or a nodal origin of melanoma.
  • Accurate diagnosis and understanding MUP are crucial for effective patient management.

Purpose of the Study:

  • To present and analyze a cohort of 24 patients diagnosed with metastatic melanoma of unknown primary site.
  • To characterize the clinical features and demographic profiles of patients with MUP.
  • To discuss the follow-up and outcomes for this specific patient group.

Main Methods:

  • Retrospective case series analysis.
  • Review of clinical data, including patient demographics, tumor characteristics, and treatment history.
  • Follow-up data collection to assess patient outcomes and survival.

Main Results:

  • The study details the characteristics of 24 patients with MUP.
  • Analysis includes presenting features, diagnostic pathways, and treatment responses.
  • Follow-up information provides insights into the clinical course and prognosis of these patients.

Conclusions:

  • Metastatic melanoma of unknown primary site presents unique diagnostic and management considerations.
  • Understanding the characteristics and outcomes of MUP patients is essential for improving clinical practice.
  • Further research into the origins and optimal treatment of MUP is warranted.